2. UroToday Home
  3. Video Lectures

COVID-19 and Genitourinary Cancers Videos

Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic, Journal Club - Christopher Wallis & Zachary Klaassen
COVID-19 and Cancer: Current Challenges and Perspectives - Ziad Bakouny, Jessica Hawley, and Corrie A. Painter
Outcomes Related to Cancer Treatments in Patients with COVID-19 from the CCC19 Registry Analysis- Ali Khaki, Jeremy Warner & Petros Grivas
The OncCOVID App – Assessing the Risk of a Cancer Patient Contracting COVID-19 vs Delaying Diagnosis or Treatment - Daniel Spratt
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care - Re-envisioning the Future - Zachary Klaassen and Christopher J.D. Wallis
Impacts of COVID-19 on Clinical Practice and in Research in Spain - Elena Castro
Working Together to Address the Health Crisis of COVID-19 - Stephen Freedland
Delivering Life Saving Care While Limiting COVID-19 Exposure - Sumit Subudhi
Managing The COVID-19 Infection Rate and Continuing GU Cancer Treatment in the UK During the Ongoing Pandemic - Thomas Powles
Efforts to Prevent Further Resurgence of COVID-19, An Update from Galveston, Texas - Stephen Williams
Strategies For Treating Genitourinary Cancer in the COVID-19 Era - Ashish Kamat
The COVID-19 Impact in New Orleans and on GU Cancer Care - A. Oliver Sartor
The COVID-19 and Cancer Consortium: Understanding the Effects of COVID-19 on Patients with GU Cancers - Petros Grivas
Bladder Cancer in Times of COVID-19 in India - Pradeep P. Rao
Impacts of Testicular and Penile Cancer Treatment Delays During the COVID-19 Pandemic - Zach Klaassen & Chris Wallis
Impacts of Kidney Cancer Treatment Delays During the COVID-19 Pandemic - Zachary Klaassen & Christopher Wallis
Interim Treatment Change Options for GU Malignancies During the COVID-19 Pandemic - Endorsed by NHS England- Nicholas James
Post-Pandemic Routine Is a Threat: Healthcare Professionals Will Probably Pay the Price - Markus Kuenkel
Maintaining Quality of Care GU Cancer Treatment During the Plateau Phase of COVID-19 in British Columbia - Kim Chi
Implementation of Remote Care and Modifications to Managing Prostate Cancer Trials During the COVID-19 Pandemic - Tomasz M. Beer
The Impact of COVID-19 on The Delivery of GU Cancer Treatment - Neeraj Agarwal
Expanding Access to GU Cancer Care Through Telehealth and Prioritizing Systemic Therapies for Genitourinary Malignancies - Srikala Sridhar
The Impact of Treatment Delays on Prostate Cancer During the COVID-19 Pandemic - Zach Klaassen & Chris Wallis
Reflecting on The Impact of COVID-19 and GU Cancer Care from Sheffield England - Carmel Pezaro
BCG Vaccine for Health Care Workers as Defense Against COVID 19: The BADAS Trial - Paul K. Hegarty
The Impact of the COVID-19 Pandemic in Australia - Declan Murphy
Genitourinary Cancer Management During COVID-19 Pandemic Dana-Farber/Brigham and Women’s Cancer Center Proposed Clinical Guidelines - Toni Choueiri
Impact on Bladder Cancer of Treatment Delays During the COVID-19 Pandemic - Zachary Klaassen & Christopher J. D. Wallis
Balancing the Risk of Delaying GU Cancer Treatments with the Risk of COVID-19 – Pedro Barata
The COVID-19 Pandemic Impacting Bladder Cancer Care in NYC - Matthew Galsky
TMPRSS2 and COVID-19: Serendipity or Opportunity for Intervention? Lorelei Mucci & Philip Kantoff
Managing GU Cancer Care During The COVID-19 Pandemic in New York - Charles Drake
The Rapidly Evolving Impact of the COVID-19 Pandemic on Managing GU Cancer Malignancies in New Orleans - Oliver Sartor
How the Cancer Programs in New York Have Adapted During the COVID-19 Pandemic - William Oh
Experts Review Rising Concerns of Kidney Associated Complications with COVID-19
The COVID-19 Pandemic Impacting GU Cancer Care in London - Tom Powles
Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 and Beyond - Neal Shore
NCCN Localized Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic - Edward M. Schaeffer
NCCN Metastatic Castration-Resistant Prostate Cancer Patient Treatment Considerations During the COVID-19 Pandemic - Edward M. Schaeffer and Alicia Morgans
The COVID-19 Pandemic Impacting Clinical Urology in Los Angeles - Stephen Freedland
COVID-19: A View Within the Pandemic Inside the Healthcare System and Bladder Cancer Care - Stephen Williams
COVID-19 Pandemic and GU Cancer Care in Spain - Elena Castro
COVID-19 Pandemic Impacting GU Cancer Care in Montreal Canada - Fred Saad
Treatment Considerations for Patients with Bladder Cancer in the Face of COVID-19 - Joshua Meeks
The BADAS Trial: BCG Vaccination Against SARS-CoV-2 to Protect Health Care Workers by Enhanced Trained Immune Responses - Ashish Kamat
The COVID-19 Pandemic and the Impact on GU Cancer Care - Charles J. Ryan
Kidney Cancer Patient Survey Findings: Impacts from the COVID-19 Pandemic - Dena Battle
COVID-19 Impacting GU Cancer Care and Nuclear Medicine - Phillip Koo
From the Frontlines of the COVID-19 Pandemic in France - Karim Fizazi
COVID-19 and Cancer Consortium (CCC19) - Jeremy Warner -Ali Khaki - Petros Grivas
COVID-19 Crisis is Transforming GU Oncology Care in San Francisco - Hala Borno
COVID-19 and Global Urologic Surgery Disruptions - Bertrand Tombal and Neal Shore
Managing GU Cancer Care during the Disruption of the COVID-19 Pandemic - Tomasz Beer
Navigating GU Oncology Care during the COVID-19 Pandemic - Petros Grivas
How COVID-19 Is Impacting Cancer Care in NYC - William Oh
COVID-19 and Cancer Care at St. Barts Cancer Institute in London UK - Thomas Powles
Safe and Effective Cancer Care During the COVID-19 Pandemic - Toni Choueiri
COVID-19 Impacting GU Cancer Care in New Orleans at Tulane Cancer Center - A. Oliver Sartor
Considerations of GU Cancer Patients Treatments in the New Reality of COVID-19 - Petros Grivas